Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Archer Materials LimitedTelephone
61.8.8272.3288
Address
Frome Road Lot Fourteen Adelaide, South Australia (SA) 5000
Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.17 - 0.64
Trade Value (12mth)
AU$33,728.00
1 week
0%
1 month
10.87%
YTD
-38.55%
1 year
-42.05%
All time high
3.08
EPS 3 yr Growth
-46.00%
EBITDA Margin
N/A
Operating Cashflow
-$5m
Free Cash Flow Return
-20.10%
ROIC
-20.10%
Interest Coverage
N/A
Quick Ratio
21.00
Shares on Issue (Fully Dilluted)
255m
HALO Sector
Industrials
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.04
Date | Announcements |
---|---|
14 October 24 |
Departure of CEO (update)
×
Departure of CEO (update) |
10 October 24 |
Agreement signed with foundry to manufacture TMR sensors
×
Agreement signed with foundry to manufacture TMR sensors |
04 October 24 |
Quarterly Activity Report & Appendix 4C
×
Quarterly Activity Report & Appendix 4C |
30 September 24 |
Archer develops new manufacturable carbon quantum material
×
Archer develops new manufacturable carbon quantum material |
03 September 24 |
Proof of concept devices to improve 12CQ chip spin detection
×
Proof of concept devices to improve 12CQ chip spin detection |
28 August 24 |
Appendix 4E and 2024 Annual Report
×
Appendix 4E and 2024 Annual Report |
28 August 24 |
2024 Corporate Governance Statement and Appendix 4G
×
2024 Corporate Governance Statement and Appendix 4G |
27 August 24 |
Biochip experiments begin to develop kidney disease testing
×
Biochip experiments begin to develop kidney disease testing |
16 August 24 |
New Integrated biochip gFET to bolster functionality
×
New Integrated biochip gFET to bolster functionality |
26 July 24 |
Quarterly Activity Report & Appendix 4C
×
Quarterly Activity Report & Appendix 4C |
23 July 24 |
New Biochip gFET test procedure and process developed
×
New Biochip gFET test procedure and process developed |
18 July 24 |
Quantum technology project update
×
Quantum technology project update |
15 July 24 |
Management restructure
×
Management restructure |
12 July 24 |
Departure of CEO
×
Departure of CEO |
28 June 24 |
Notification of cessation of securities - AXE
×
Notification of cessation of securities - AXE |
17 June 24 |
Archer Biochip gFET design fabricated on a six-inch wafer
×
Archer Biochip gFET design fabricated on a six-inch wafer |
09 May 24 |
Notification of cessation of securities - AXE
×
Notification of cessation of securities - AXE |
29 April 24 |
Quarterly Activity Report & Appendix 4C
×
Quarterly Activity Report & Appendix 4C |
09 April 24 |
Change in substantial holding for CMX
×
Change in substantial holding for CMX |
05 April 24 |
Sharecafe Investor Presentation
×
Sharecafe Investor Presentation |
02 April 24 |
Notification of cessation of securities - AXE
×
Notification of cessation of securities - AXE |
02 April 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
25 March 24 |
Archer and EPFL develop a single chip pulsed ESR microsystem
×
Archer and EPFL develop a single chip pulsed ESR microsystem |
11 March 24 |
Archer miniaturises Biochip gFET chip design
×
Archer miniaturises Biochip gFET chip design |
16 February 24 |
Appendix 4D and Half Year Financial Report
×
Appendix 4D and Half Year Financial Report |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.